AI drug discovery

AI and machine learning used to discover and develop drugs, and the companies doing it.

All insights

Showing 7 of 7 results
Biostrat Brief

Frontier AI Is Coming for Bio. Which Moats Survive?

Part 2 of our frontier AI x bio series: the five ways AI x bio moats fail as frontier labs absorb the stack, and the four positions that survive.

Frontier and generative AI
Read 6 October 2026
Biostrat Brief

The changing wave of AI adoption in pharma: From molecules to models

Pharma has moved from partnering for AI-made molecules to licensing models and owning the capability. Rent, build or buy: how to choose, and what it means for techbio.

AI drug discovery
Read 25 August 2026
Articles

Digital Twins in Healthcare and Drug Discovery: From Idea to Success Stories

Exploring the transformative potential of digital twins in healthcare and pharmaceutical research.

AI drug discovery
Read 20 April 2025
Articles

Adopting AI Platforms: A Structured Framework for Thoughtful Platform Evaluation

A comprehensive guide to evaluating and implementing AI platforms in pharmaceutical research and development.

AI drug discovery
Read 15 January 2024
Articles

Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?

Examining the current state and future potential of AI in antibody drug development.

AI drug discovery
Read 12 July 2023
Articles

The AI Productivity Game in Pharma

Analyzing how pharmaceutical companies can leverage AI to enhance productivity and innovation.

AI drug discovery
Read 28 June 2023
Articles

Tech Providers or Biotechs? The Quest for an Optimal Business Model in AI Drug Discovery

An analysis of evolving business models in the AI-driven drug discovery landscape.

Platform biotechs
Read 19 March 2021

The BioStrat Brief

A dealmaker's take on M&A, fundraising, strategy and markets in life sciences and healthcare

The BioStrat Brief draws on perspectives and observations gathered through our work. Each new edition is published on LinkedIn.

Read the Brief on LinkedIn

AI drug discovery

AI and machine learning used to discover and develop drugs, and the companies doing it.

All insights

Showing 7 of 7 results
Biostrat Brief

Frontier AI Is Coming for Bio. Which Moats Survive?

Part 2 of our frontier AI x bio series: the five ways AI x bio moats fail as frontier labs absorb the stack, and the four positions that survive.

Frontier and generative AI
Read 6 October 2026
Biostrat Brief

The changing wave of AI adoption in pharma: From molecules to models

Pharma has moved from partnering for AI-made molecules to licensing models and owning the capability. Rent, build or buy: how to choose, and what it means for techbio.

AI drug discovery
Read 25 August 2026
Articles

Digital Twins in Healthcare and Drug Discovery: From Idea to Success Stories

Exploring the transformative potential of digital twins in healthcare and pharmaceutical research.

AI drug discovery
Read 20 April 2025
Articles

Adopting AI Platforms: A Structured Framework for Thoughtful Platform Evaluation

A comprehensive guide to evaluating and implementing AI platforms in pharmaceutical research and development.

AI drug discovery
Read 15 January 2024
Articles

Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?

Examining the current state and future potential of AI in antibody drug development.

AI drug discovery
Read 12 July 2023
Articles

The AI Productivity Game in Pharma

Analyzing how pharmaceutical companies can leverage AI to enhance productivity and innovation.

AI drug discovery
Read 28 June 2023
Articles

Tech Providers or Biotechs? The Quest for an Optimal Business Model in AI Drug Discovery

An analysis of evolving business models in the AI-driven drug discovery landscape.

Platform biotechs
Read 19 March 2021

The BioStrat Brief

A dealmaker's take on M&A, fundraising, strategy and markets in life sciences and healthcare

The BioStrat Brief draws on perspectives and observations gathered through our work. Each new edition is published on LinkedIn.

Read the Brief on LinkedIn

AI drug discovery

AI and machine learning used to discover and develop drugs, and the companies doing it.

All insights

Showing 7 of 7 results
Biostrat Brief

Frontier AI Is Coming for Bio. Which Moats Survive?

Part 2 of our frontier AI x bio series: the five ways AI x bio moats fail as frontier labs absorb the stack, and the four positions that survive.

Frontier and generative AI
Read 6 October 2026
Biostrat Brief

The changing wave of AI adoption in pharma: From molecules to models

Pharma has moved from partnering for AI-made molecules to licensing models and owning the capability. Rent, build or buy: how to choose, and what it means for techbio.

AI drug discovery
Read 25 August 2026
Articles

Digital Twins in Healthcare and Drug Discovery: From Idea to Success Stories

Exploring the transformative potential of digital twins in healthcare and pharmaceutical research.

AI drug discovery
Read 20 April 2025
Articles

Adopting AI Platforms: A Structured Framework for Thoughtful Platform Evaluation

A comprehensive guide to evaluating and implementing AI platforms in pharmaceutical research and development.

AI drug discovery
Read 15 January 2024
Articles

Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?

Examining the current state and future potential of AI in antibody drug development.

AI drug discovery
Read 12 July 2023
Articles

The AI Productivity Game in Pharma

Analyzing how pharmaceutical companies can leverage AI to enhance productivity and innovation.

AI drug discovery
Read 28 June 2023
Articles

Tech Providers or Biotechs? The Quest for an Optimal Business Model in AI Drug Discovery

An analysis of evolving business models in the AI-driven drug discovery landscape.

Platform biotechs
Read 19 March 2021

The BioStrat Brief

A dealmaker's take on M&A, fundraising, strategy and markets in life sciences and healthcare

The BioStrat Brief draws on perspectives and observations gathered through our work. Each new edition is published on LinkedIn.

Read the Brief on LinkedIn